The molecular mechanisms underlying the cardioprotective effect of fabomotizole were studied using the translational rat model of alcoholic cardiomyopathy developed by us. It was shown that intraperitoneal administration of fabomotizole (15 mg/kg) for 28 days to animals with alcoholic cardiomyopathy contributes to normalization of the expression of mRNA of genes of regulatory proteins СаМ (p=0.00001), Ерас1 (p=0.021), and Ерас2 (p=0.018) and receptors RyR2 (p=0.0031) and IP3R2 (p=0.006) in the myocardium of the myocardium of the left ventricle that is enhanced in control animals (p<0.05). These changes were accompanied by echocardiographically documented decrease in the degree of left ventricle remodeling and improvement of its inotropic function.
Similar content being viewed by others
References
Kozhevnikova LM, Tsorin IB, Stolyaruk VN, Sukhanova IF, Vititnova MB, Nikiforova TD, Kolik LG, Kryzhanovskii SA. Epac Proteins and Calmodulin as Possible Arrhythmogenesis Trigger in Alcoholic Cardiomyopathy. Bull. Exp Biol. Med. 2018;165(5):613-616. https://doi.org/10.1007/s10517-018-4225-4
Kryzhanovskii SA, Kolik LG, Tsorin IB, Ionova EO, Stolyaruk VN, Sorokina AV, Vititnova MB, Miroshkina IA. Evidence of Echocardiography Validity in Model Experiments on Small Animals. Bull. Exp. Biol. Med. 2016;161(3):434-8. https://doi.org/10.1007/s10517-016-3432-0
Kryzhanovskii SA, Stolyaruk VN, Vititnova MB, Tsorin IB, Seredenin SB. Pleiotropic (cardiotropic)effects of anxiolytic Afobazole (review of experimental studies). Terapevt. 2012;(1):32-40. Russian.
Kryzhanovskii SA, Tsorin IB, Kolik LG, Stolyaruk VN, Vititnova MB, Ionova EO, Sorokina AV, Miroshkina IA, Durnev AD, Seredenin SB. About possibility of the use of Afobazole for treatment of alcoholic cardiomyopathy and prevention of its concomitant complications. Mol. Med. 2015;(4):35-42. Russian.
Resolution of the Panel Discussion “Contribution of Blood Circulation Diseases in Total Mortality: Questions and Problems”, May 11, 2016, Moscow. Kompleks. Probl. Serd.-Sosud. Zabol. 2016;5(3):113-116. Russian.
Semyonova VG, Antonova OI, Evdokushkina GN, Gavrilova NS. Losses of the population of Russia in 2000-2008 caused by alcohol: scales, structure, and tendencies. Sots. Aspekty Zdorov’ya Nqaseleniya. 2010;(2). URL: http://vestnik.mednet.ru/content/view/188/30/
Chazov EI. Sudden death. Medicus Amicus: site for physicians and pharmacists. URL: http://www.medicusamicus.com/index.php?action=2x1229x1
Harzheim D, Movassagh M, Foo RS, Ritter O, Tashfeen A, Conway SJ, Bootman MD, Roderick HL. Increased InsP3Rs in the junctional sarcoplasmic reticulum augment Ca2+ transients and arrhythmias associated with cardiac hypertrophy. Proc. Natl Acad. Sci. USA. 2009;106(27):11 406-11 411. https://doi.org/10.1073/pnas.0905485106
Hohendanner F, McCulloch AD, Blatter LA, Michailova AP. Calcium and IP3 dynamics in cardiac myocytes: experimental and computational perspectives and approaches. Front. Pharmacol. 2014;5:35. https://doi.org/10.3389/fphar.2014.00035
Hothi SS, Gurung IS, Heathcote JC, Zhang Y, Booth SW, Skepper JN, Grace AA, Huang CL. Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart. Pflugers Arch. 2008;457(2):253-270. https://doi.org/10.1007/s00424-008-0508-3
Mammucari C, Patron M, Granatiero V, Rizzuto R. Molecules and roles of mitochondrial calcium signaling. Biofactors. 2011;37(3):219-227. https://doi.org/10.1002/biof.160
Nikolaienko R, Bovo E, Zima AV. Redox Dependent Modifications of Ryanodine Receptor: Basic Mechanisms and Implications in Heart Diseases. Front. Physiol. 2018;9:1775. https://doi.org/10.3389/fphys.2018.01775
Oestreich EA, Wang H, Malik S, Kaproth-Joslin KA, Blaxall BC, Kelley GG, Dirksen RT, Smrcka AV. Epac-mediated activation of phospholipase C(epsilon) plays a critical role in beta-adrenergic receptor-dependent enhancement of Ca2+ mobilization in cardiac myocytes. J. Biol. Chem. 2007;282(8):5488-5495. https://doi.org/10.1074/jbc.M608495200
Tagashira H, Bhuiyan MS, Fukunaga K. Diverse regulation of IP3 and ryanodine receptors by pentazocine through σ1-receptor in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2013;305(8):H1201-H1212. https://doi.org/10.1152/ajpheart.00300.2013
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 171, No. 1, pp. 54-58, January, 2021
Rights and permissions
About this article
Cite this article
Kryzhanovskii, S.A., Kozhevnikova, L.M., Vititnova, M.B. et al. On the Mechanism of Cardioprotective Effect of Fabomotizole in Alcoholic Cardiomyopathy. Bull Exp Biol Med 171, 41–44 (2021). https://doi.org/10.1007/s10517-021-05168-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-021-05168-6